Logo

... as Syngene Says Undisclosed Pharma Is Using Its Imaging Tech to Find Protein Targets

Jun 14, 2006

NEW YORK, June 14 (GenomeWeb News) - Syngene today said that an undisclosed "leading USpharmaceutical company" is using its imaging system to help it discover protein drug targets.

 

Researchers at this drug maker are using the technology to automatically assess around 150 2D protein gels per week. These gels are up to 26 cm x 26 cm and are stained with dyes including Sypro Orange, Sypro Ruby, Sybr Green, Coomassie Blue, and Pro-Q Diamond.

 

Financial terms of the deal were not disclosed.

Breaking News
The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.